Jane Yue
Directeur/Bestuurslid bij Canadian-Chinese Professional Accountants Association
Actieve functies van Jane Yue
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Canadian-Chinese Professional Accountants Association | Directeur/Bestuurslid | 21-10-2010 | - |
Loopbaan van Jane Yue
Eerdere bekende functies van Jane Yue
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Financieel Directeur/CFO | 10-11-2009 | 20-01-2011 |
Bedrijfssecretaris | 18-11-2009 | 20-01-2011 |
Opleiding van Jane Yue
University of British Columbia | Graduate Degree |
Statistieken
Internationaal
Canada | 4 |
Operationeel
Director of Finance/CFO | 1 |
Corporate Secretary | 1 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
Canadian-Chinese Professional Accountants Association |